Meridian Wealth Management’s Biogen BIIB Stock Holding History

Meridian Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,179	Closed	-$305K	–	217
2023 Q4	$305K	Sell	1,179 -4,487	-79%	-$1.1M	0.02%	497
2023 Q3	$1.46M	Sell	5,666 -42	-0.7%	-$11.2K	0.09%	190
2023 Q2	$1.63M	Buy	5,708 +2	+0%	+$595	0.14%	140
2023 Q1	$1.59M	Buy	5,706 +4	+0.1%	+$1.11K	0.14%	150
2022 Q4	$1.58M	Sell	5,702 -30	-0.5%	-$8.47K	0.15%	138
2022 Q3	$1.53M	Buy	+5,732	New	+$1.22M	0.16%	132
2019 Q3	–	Sell	-198	Closed	-$46.2K	–	225
2019 Q2	$46.2K	Buy	+198	New	+$45.7K	0.02%	383
2018 Q1	–	Sell	-5,381	Closed	-$1.69M	–	179
2017 Q4	$1.69M	Hold	5,381	–	–	1.04%	20
2017 Q3	$1.69M	Buy	+5,381	New	+$1.59M	1.07%	20

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meridian Wealth Management's BIIB Position: Q1 2024 in Review

Meridian Wealth Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,179 shares — an estimated $305K sold.

Meridian Wealth Management first reported a position in BIIB in Q3 2017 and held it in 9 quarters. The position peaked at $1.69M in Q4 2017. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

Meridian Wealth Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
Meridian Wealth Management sold 1,179 Biogen shares in Q1 2024, an estimated $305K.
Meridian Wealth Management first reported a position in Biogen in Q3 2017 and held it in 9 quarters.
Meridian Wealth Management's Biogen position peaked at $1.69M in Q4 2017.
955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Meridian Wealth Management's 13F filing for Q1 2024, filed 25 Apr 2024.